Flu hospital admissions in the United States jumped by more than a fifth in a single week in mid-November, as an early flu season driven almost entirely by the H1N1 strain pushed hospitalisation rates to their highest level for this point in the year in a decade and a half.
Hospitals reported 11,734 laboratory-confirmed flu admissions in the week ending 14 November, up from 9,584 the week before, according to the Centers for Disease Control and Prevention. That is a rise of 2,150 admissions, or 22.4 percent, in seven days, and it follows several weeks of steady growth that began earlier than usual this autumn.
The numbers matter because they are not just a one-week blip. In the CDC’s FluSurv-NET network, which tracks hospitalisations in selected counties across the country, the cumulative hospitalisation rate has now reached 12.0 per 100,000 people. That is the highest rate recorded at this stage of a flu season since the 2010-11 season, the first winter after the 2009 pandemic. In other words, this season is filling hospital beds faster, earlier, than almost any season in living memory.
The strain behind the surge is a familiar one. The season is being driven almost entirely by influenza A(H1N1)pdm09, the strain that emerged in the 2009 pandemic and has circulated every winter since. Of the 365 influenza A viruses subtyped by public health laboratories in the week ending 14 November, 352 of them, or 96.4 percent, were H1N1. Only five of the 613 flu detections reported by those laboratories that week were influenza B. The CDC said in an earlier update that most of the H1N1 viruses detected this season belong to a genetic subgroup known as D.3.1.1.
That dominance is worth understanding, because it shapes who gets hit hardest and how well the vaccine works. H1N1 tends to strike younger adults and children harder than the H3N2 strain, which more often hits older people. In the week ending 7 November, adults aged 65 and over still had the highest admission rate, at 8.6 per 100,000, followed by children aged four and under and adults aged 50 to 64. But the pattern of an H1N1 season is that it spreads fast through schools, workplaces and families, and it can catch people off guard because it arrives early, before many have thought about getting vaccinated.
The human cost is already visible. Seven children have died of flu-related illness so far this season, up from five a week earlier, and both of the newly reported deaths were associated with H1N1 viruses. The CDC does not release the age, location or vaccination status of individual children who die. In Ohio, health officials reported the state’s first flu-associated paediatric death of the 2026-27 season, a teenager under 18 from Ross County. Behind each of those numbers is a family that expected an ordinary winter illness and got something far worse.
For the season as a whole, the CDC estimates that there have been at least 3.7 million flu illnesses, 50,000 hospitalisations and 2,800 deaths so far. Those are estimates, not counts, and they will rise as the season goes on. The agency’s FluSight forecasting programme points to further increases in the weeks ahead, which is the normal shape of a flu season: a slow climb through autumn, a sharp rise as winter sets in, and a peak somewhere in December or January. What is unusual this year is how early the climb started, and how steep it already is.
There is a note of caution in the official picture that is worth holding on to. Despite the early surge, the CDC still classifies the overall severity of the season as low, a judgement based on several measures, including the proportion of patients who need intensive care and the number of deaths. Hospital admissions are high for this point in the season, but they are not yet at the levels seen at the peak of a bad winter. The season could still go either way. An early start does not guarantee a severe winter, but it does mean there is less time to prepare, and less room for complacency.
That is where vaccination comes in. The flu vaccine does not prevent every infection, and it never has. The CDC reported a preliminary vaccine effectiveness of 36 percent for the previous season, which means it cut the risk of a flu illness needing medical care by a little more than a third. That sounds modest, but it is not the whole story. The vaccine is better at preventing the outcomes that matter most: hospitalisation, intensive care, and death. For older adults, young children, pregnant women and people with long-term conditions such as asthma, diabetes and heart disease, it is the difference between a bad week in bed and a bed in a hospital ward.
The timing matters too. It takes about two weeks for the vaccine to build up protection, which means that a jab taken now will not help for a fortnight, and a jab taken in December may arrive after the peak has passed. Health officials have been urging people not to wait, and this year’s early surge is the reason why. Every week of delay is a week in which the virus is already circulating widely, and in which an unvaccinated person is walking through it unprotected.
There are other things people can do, and they are the same unglamorous habits that work every winter. Stay home when you are ill, and keep children home from school when they have a fever. Wash your hands often, and cover coughs and sneezes. If you are in a high-risk group and you develop flu symptoms, call your doctor early, because antiviral medicines such as oseltamivir work best when started within the first two days.
The flu is easy to dismiss. Most people who catch it recover in a week, and most years it passes without much notice. But a season like this one is a reminder of what it can do when it arrives early and spreads quickly: thousands in hospital in a single week, children dying, and a hospitalisation rate not seen at this stage of the year since 2010. The vaccine is not perfect, and it is not too late, but the window is closing. If you have been meaning to get it, this is the week to do it.
